mir-92a, a small non-coding rna, is a newly discovered biomarker with high sensitivity and specificity to crc. recolontm mir-92a assay kit, the 1st cfda approved stool-based colorectal cancer diagnostic kit, works through detecting mir-92a level directly from crc cells shed from lining of human colon and eventually excreted in the stool. by co-working with existing clinical tests, recolontm serves as an effective tool for crc screening, early diagnosis and postoperative monitoring.
|
|